Mechanism of Action of Valproate (Mood Stabilizer & Antiepileptic)

Introduction

Valproate (also known as valproic acid or divalproex sodium) is a widely used mood stabilizer and broad-spectrum antiepileptic. It is highly effective in treating bipolar disorder, generalized seizures, migraine prophylaxis, and acute mania. Its mechanism involves increased GABA levels, modulation of ion channels, and inhibition of intracellular signaling pathways.

It’s frequently tested in exams like USMLE, NCLEX, GPAT, and NEET-PG due to its broad clinical importance and unique pharmacological profile.

---

Stepwise Mechanism of Action of Valproate

1. Inhibition of GABA transaminase
   Valproate inhibits GABA transaminase, the enzyme responsible for GABA degradation, thereby increasing CNS GABA levels and enhancing inhibitory neurotransmission.
2. Stimulation of glutamic acid decarboxylase (GAD)
   It enhances GAD activity, increasing the synthesis of GABA from glutamate.
3. Blockade of voltage-gated sodium channels
   Valproate inhibits voltage-gated Na⁺ channels, prolonging the inactivation state, which stabilizes neuronal membranes and prevents seizure propagation.
4. Inhibition of T-type calcium channels
   In the thalamic neurons, valproate blocks T-type Ca²⁺ channels, especially useful in absence seizures.
5. Histone deacetylase (HDAC) inhibition
   At the epigenetic level, valproate inhibits HDAC, altering gene expression and contributing to neuroprotection.

---

How Valproate Works:

1. Inhibition of Voltage-Gated Sodium Channels:
   • Valproate inhibits voltage-gated sodium channels in neuronal membranes, stabilizing the membrane potential.
   • By blocking sodium influx, it reduces neuronal excitability, helping to prevent seizures and elevated mood states (such as in bipolar disorder).
2. Enhancement of GABAergic Transmission:
   • Valproate increases the availability of GABA (gamma-aminobutyric acid), the primary inhibitory neurotransmitter in the brain.
   • It increases GABA synthesis and reduces GABA degradation, leading to enhanced GABAergic transmission and reduced excitability of neurons.
   • This GABAergic action is important for mood stabilization and anti-seizure effects.
3. Inhibition of Histone Deacetylases (HDACs):
   • Valproate acts as a histone deacetylase (HDAC) inhibitor, affecting chromatin structure and gene expression.
   • By inhibiting HDACs, it leads to increased acetylation of histones, promoting gene transcription that may help in neuroprotection and reducing neuronal damage during seizures.
4. Modulation of the NMDA Receptor:
   • Valproate has antagonistic effects on NMDA (N-Methyl-D-Aspartate) receptors, reducing glutamate-mediated excitotoxicity in the brain.
   • This helps to prevent neuronal damage during seizures and can also have neuroprotective effects.
5. Effect on Calcium Channels:
   • Valproate has an effect on voltage-gated calcium channels, which is thought to contribute to its anticonvulsant properties and its mood-stabilizing effects.
6. Mood Stabilization:
   • In addition to its anticonvulsant properties, Valproate also exerts mood-stabilizing effects in patients with bipolar disorder. Its GABAergic activity and ability to modulate excitatory neurotransmission help reduce manic episodes and prevent the recurrence of mood swings.

---

Pharmacokinetic Parameters of Valproate

Parameter	Value
Bioavailability	~100% (oral)
Half-life	9–16 hours
Protein binding	80–90%
Metabolism	Hepatic (CYP450-independent pathways)
Excretion	Renal (glucuronidated metabolites)
Therapeutic range	50–100 μg/mL

---

Clinical Uses of Valproate

• Bipolar disorder (acute mania and maintenance)
• Generalized tonic-clonic seizures
• Absence seizures
• Myoclonic seizures
• Mixed seizure types
• Migraine prophylaxis
• Schizoaffective disorder (off-label)

---

Adverse Effects of Valproate

• Hepatotoxicity – especially in children under 2 years
• Pancreatitis
• Weight gain
• Alopecia
• Tremor
• Teratogenicity – causes neural tube defects (e.g., spina bifida)
• GI upset – nausea, vomiting
• Hyperammonemia and encephalopathy
• Thrombocytopenia
• PCOS (in women)

---

Comparative Analysis: Valproate vs Carbamazepine

Feature	Valproate	Carbamazepine
Broad-spectrum use	Yes	No (partial and tonic-clonic)
Sodium channel effect	Yes	Yes
T-type Ca²⁺ channel	Yes	No
Autoinduction	No	Yes
Hepatotoxicity	Higher in children	Moderate
Teratogenicity	Neural tube defects	Cleft palate

---

Practice MCQs

Q1. Valproate increases GABA levels by:
a. Inhibiting GABA synthesis
b. Stimulating GABA transaminase
c. Inhibiting GABA transaminase ✅
d. Activating glutamate receptors

Q2. Which ion channel is blocked by valproate?
a. L-type Ca²⁺
b. Na⁺ channels ✅
c. K⁺ channels
d. NMDA receptor

Q3. Valproate is effective in:
a. Only partial seizures
b. Absence seizures ✅
c. Status epilepticus only
d. Only myoclonic seizures

Q4. Major teratogenic effect of valproate is:
a. Ebstein anomaly
b. Cleft lip
c. Neural tube defects ✅
d. Congenital cataract

Q5. Valproate inhibits which of the following enzymes?
a. COMT
b. Monoamine oxidase
c. GABA transaminase ✅
d. Acetylcholinesterase

Q6. Valproate should be avoided in children under 2 due to:
a. Hypoglycemia
b. Hepatotoxicity ✅
c. Seizure worsening
d. Growth retardation

Q7. Valproate causes which electrolyte abnormality?
a. Hyponatremia
b. Hypokalemia
c. Hyperammonemia ✅
d. Hypercalcemia

Q8. Valproate enhances GABA synthesis by stimulating:
a. Tyrosine hydroxylase
b. Glutamic acid decarboxylase ✅
c. Dopamine beta-hydroxylase
d. MAO-B

Q9. Valproate inhibits which epigenetic enzyme?
a. Histone methyltransferase
b. DNA polymerase
c. Histone deacetylase ✅
d. RNA helicase

Q10. One of the hematological adverse effects of valproate is:
a. Hemolysis
b. Thrombocytopenia ✅
c. Leukocytosis
d. Polycythemia

---

FAQs

Q1: Can valproate be used in children?
Yes, but not preferred in children under 2 due to hepatotoxicity risk.

Q2: Is valproate effective in all types of seizures?
Yes. It’s a broad-spectrum antiepileptic, effective in absence, tonic-clonic, and myoclonic seizures.

Q3: Why is valproate avoided in pregnancy?
It’s highly teratogenic, especially causing neural tube defects.

Q4: Can valproate cause liver damage?
Yes. Monitor LFTs, especially in young children or those with metabolic disorders.

Q5: Does valproate require therapeutic drug monitoring?
Yes. Maintain serum levels between 50–100 μg/mL.

---

References

• KD Tripathi – Essentials of Medical Pharmacology
• Goodman & Gilman – The Pharmacological Basis of Therapeutics
• Review of Pharmacology – Sparsh Gupta
• NCBI: https://www.ncbi.nlm.nih.gov/books/NBK548290/

---